AVITA Medical, Inc. (AVHHL)
USD 2.3
(0.0%)
USD 2.3
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -28.04 Million | -22.74 Million | -32.96 Million | -17.51 Million | -8.55 Million | -7.93 Million |
| Net Income | -39.16 Million | -42.03 Million | -60.9 Million | -17.2 Million | -11.51 Million | -7.77 Million |
| Depreciation & Amortization | 834.33 Thousand | 465 Thousand | 673.78 Thousand | 148.62 Thousand | 139.7 Thousand | 83.72 Thousand |
| Deferred income taxes | - | 393 Thousand | - | - | - | - |
| Stock-based compensation | 10.27 Million | 16.59 Million | 24.04 Million | 1.96 Million | 1.58 Million | 956.65 Thousand |
| Change in working capital | -1.79 Million | 1.33 Million | -1.6 Million | -1.53 Million | 101.43 Thousand | -1.24 Million |
| Other non-cash items | 1.81 Million | 502 Thousand | 4.82 Million | -883.62 Thousand | 1.12 Million | 43.79 Thousand |
| Investing Cash Flow | -28.39 Million | -847 Thousand | -1.22 Million | -493.15 Thousand | 195.24 Thousand | -47.84 Thousand |
| Investments in PPE | -663.94 Thousand | -847 Thousand | -854.91 Thousand | -493.15 Thousand | -432.59 Thousand | -48.28 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -27.73 Million | - | -372.39 Thousand | - | 627.83 Thousand | 440.00 |
| Financing Cash Flow | 1.32 Million | 77.05 Million | 111.65 Million | 28.77 Million | 8.23 Million | 9.36 Million |
| Debt repayment | - | -42 Thousand | -60.85 Thousand | -82.41 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 81.7 Million | - | - | - | - |
| Other Financing Activities | 1.32 Million | -4.6 Million | 111.71 Million | 28.85 Million | 8.23 Million | 9.36 Million |
| Accounts receivables | -580.21 Thousand | -729 Thousand | -1.05 Million | -36.47 Thousand | -49.04 Thousand | -516.05 Thousand |
| Accounts payables | - | 2.3 Million | - | - | - | - |
| Inventory | -544.96 Thousand | -468 Thousand | -678.13 Thousand | -127 Thousand | 333.13 Thousand | -776.1 Thousand |
| Other working capital | -672.75 Thousand | 219 Thousand | 133.3 Thousand | -1.37 Million | -182.65 Thousand | 47.44 Thousand |
| Cash at beginning of period | 147.95 Million | 20.37 Million | 29.02 Million | 3.79 Million | 4.17 Million | 2.96 Million |
| Cash at end of period | 26.68 Million | 73.84 Million | 106.99 Million | 14.84 Million | 3.79 Million | 4.17 Million |
| Capital Expenditure | -663.94 Thousand | -847 Thousand | -854.91 Thousand | -493.15 Thousand | -432.59 Thousand | -48.28 Thousand |
| Effect of forex changes on cash | -38.19 Thousand | 3000.00 | 4347.00 | 137.81 Thousand | -257.23 Thousand | -169.1 Thousand |
| Net cash flow / Change in cash | -121.27 Million | 53.46 Million | 77.97 Million | 11.05 Million | -381.38 Thousand | 1.2 Million |
| Free Cash Flow | -28.7 Million | -23.59 Million | -33.81 Million | -18 Million | -8.99 Million | -7.98 Million |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -13.55 Million | -15.59 Million | -13.79 Million | -39.16 Million | -7.86 Million | -8.73 Million |
| Depreciation & Amortization | 255.11 Thousand | 219.2 Thousand | 201.93 Thousand | 834.33 Thousand | 190.95 Thousand | 215.76 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 3.78 Million | 1.71 Million | 3.94 Million | 10.27 Million | 1.78 Million | 2.24 Million |
| Change in working capital | -3.24 Million | -441.41 Thousand | -5.67 Million | -1.79 Million | 696.25 Thousand | 689.5 Thousand |
| Other non-cash items | -1.2 Million | 432.4 Thousand | 1.74 Million | 1.81 Million | 142.48 Thousand | 1.24 Million |
| Investing Cash Flow | 33.85 Million | 27.57 Million | 28.1 Million | -28.39 Million | -4.63 Million | -13.02 Million |
| Investments in PPE | -780.91 Thousand | -448.91 Thousand | -424.8 Thousand | -663.94 Thousand | -102.82 Thousand | -162.6 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 34.63 Million | 28.01 Million | 28.52 Million | -27.73 Million | -4.53 Million | -12.85 Million |
| Financing Cash Flow | 933.36 Thousand | 256.73 Thousand | 255.78 Thousand | 1.32 Million | 1.32 Million | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 933.36 Thousand | 256.73 Thousand | 255.78 Thousand | 1.32 Million | 1.32 Million | - |
| Accounts receivables | -51.33 Thousand | -1.92 Million | -1.73 Million | -580.21 Thousand | 79.32 Thousand | 512.82 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -2.18 Million | -373.84 Thousand | -1.12 Million | -544.96 Thousand | -370.16 Thousand | -104.75 Thousand |
| Other working capital | -1 Million | 1.85 Million | -2.81 Million | -672.75 Thousand | 987.1 Thousand | 281.43 Thousand |
| Cash at beginning of period | 56.27 Million | 41.95 Million | 26.68 Million | 147.95 Million | 37.23 Million | 50.6 Million |
| Cash at end of period | 79.1 Million | 56.27 Million | 41.95 Million | 26.68 Million | 26.68 Million | 37.23 Million |
| Capital Expenditure | -780.91 Thousand | -448.91 Thousand | -424.8 Thousand | -663.94 Thousand | -102.82 Thousand | -162.6 Thousand |
| Effect of forex changes on cash | -28 Thousand | 3002.80 | 1495.80 | -38.19 Thousand | 64.63 Thousand | -28.14 Thousand |
| Net cash flow / Change in cash | 22.82 Million | 14.32 Million | 15.27 Million | -121.27 Million | -10.55 Million | -13.37 Million |
| Free Cash Flow | -14.74 Million | -14.11 Million | -13.99 Million | -28.7 Million | -5.14 Million | -4.5 Million |
AMADF
9559
TAMU
0HSU
BBTN
DTIL